Universal Vision Biotechnology (3218) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 大學光

Universal Vision Biotechnology (3218) reported revenue of NT$376.8 million for Oct 2026, +8.7% year on year and +4.9% from the previous month. Revenue for Jan–Oct 2026 was NT$3.75 billion (+6.7% year on year).

Year-on-year revenue growth: 9 months in a row. →

In Oct 2026, it ranked No. 24 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$349.1 million24/10Nov 2024 NT$332.5 millionDec 2024 NT$356.5 millionJan 2025 NT$417.3 millionFeb 2025 NT$342.4 million25/02Mar 2025 NT$363.5 millionApr 2025 NT$354.6 millionMay 2025 NT$347.7 millionJun 2025 NT$320.6 million25/06Jul 2025 NT$340.1 millionAug 2025 NT$362.3 millionSep 2025 NT$322.3 millionOct 2025 NT$346.6 million25/10Nov 2025 NT$318.5 millionDec 2025 NT$368.1 millionJan 2026 NT$367.4 millionFeb 2026 NT$353.8 million26/02Mar 2026 NT$368.6 millionApr 2026 NT$380.4 millionMay 2026 NT$370.7 millionJun 2026 NT$375.4 million26/06Jul 2026 NT$405.8 millionAug 2026 NT$396.3 millionSep 2026 NT$359.3 millionOct 2026 NT$376.8 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$376.8 million+8.7%+4.9%
Sep 2026NT$359.3 million+11.5%-9.3%
Aug 2026NT$396.3 million+9.4%-2.3%
Jul 2026NT$405.8 million+19.3%+8.1%
Jun 2026NT$375.4 million+17.1%+1.2%
May 2026NT$370.7 million+6.6%-2.5%
Apr 2026NT$380.4 million+7.3%+3.2%
Mar 2026NT$368.6 million+1.4%+4.2%
Feb 2026NT$353.8 million+3.3%-3.7%
Jan 2026NT$367.4 million-11.9%-0.2%
Dec 2025NT$368.1 million+3.2%+15.6%
Nov 2025NT$318.5 million-4.2%-8.1%
Oct 2025NT$346.6 million-0.7%+7.5%
Sep 2025NT$322.3 million-0.4%-11.0%
Aug 2025NT$362.3 million-8.1%+6.6%
Jul 2025NT$340.1 million-6.0%+6.1%
Jun 2025NT$320.6 million-5.2%-7.8%
May 2025NT$347.7 million+1.4%-1.9%
Apr 2025NT$354.6 million-1.1%-2.4%
Mar 2025NT$363.5 million-1.8%+6.2%
Feb 2025NT$342.4 million+0.1%-17.9%
Jan 2025NT$417.3 million+16.3%+17.0%
Dec 2024NT$356.5 million+5.8%+7.2%
Nov 2024NT$332.5 million+4.3%-4.8%
Oct 2024NT$349.1 million+3.6%+7.9%

Jan–Oct 2026 cumulative: NT$3.75 billion (+6.7% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Universal Vision Biotechnology vs PEC / Universal Vision Biotechnology vs Lotus Pharm / Universal Vision Biotechnology vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16